Track topics on Twitter Track topics that are important to you
FluGen, an early-stage company developing vaccine candidates designed to protect against multiple types of influenza, has raised $5.5 million in debt financing. Twenty-five investors participated in the funding round, according to an SEC filing. Madison, WI-based FluGen has now raised more than $27 million from investors since launching in 2007. In July 2016, FluGen initiated […]
Original Article: FluGen, Startup Developing Universal Flu Vaccine, Raises $5.5MNEXT ARTICLE
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...